Direct oncogene-targeted cancer killing and selective tumor Treg killing through the TNFR2 receptor via dominant antibody Antagonists
A major barrier to cancer immunotherapy is the lack of selective inhibitors
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
A major barrier to cancer immunotherapy is the lack of selective inhibitors
Regenerative medicine is coming to recognize the value of a stem cell
Treatment of malignancies with Peripheral Blood Stem Cell Transplants (PBSCTs) from donors
Tumor necrosis factor (TNF) is a novel immunotherapy for type I diabetes
For authors and organisers
Find the right journal for your paper and submit your manuscript.